VXRT Vaxart Inc
Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.
$3.73 +0.21 (5.97%)
As of 05/20/2022 15:59:56 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Small cap
GICS sector: Health Care
Industry: Biotechnology
Index country: USA
Country of incorporation: USA
IPO date: 02/19/2013
Outstanding shares: 126,405,811
Average volume: 3,263,590
Market cap: $444,948,455
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol: BYWJD92
Valuation (See tab for details)
PE ratio: -5.91
PB ratio: 2.81
PS ratio: 944.69
Return on equity: -47.82%
Net income %: -16,892.57%